Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The present study was a descriptive, non-interventional, retrospective cohort study aimed at evaluating early data on adherence, persistence, and treatment patterns among patients receiving inclisiran and other lipid-lowering therapies (LLT) in a real-world setting in Germany. Analysis was carried out using the IQVIA™ LRx database.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Overall cohort | Patients receiving inclisiran |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number and percentage of patients with at least 5 months of potential follow-up who were prescribed a second dose of inclisiran | 8 months | |
| Percentage of patients who were prescribed a second dose of inclisiran between 1 and 6 months after prescription of first dose | 8 months | |
| Median time between first and second prescribed doses | 8 months |
| Measure | Description | Time Frame |
|---|---|---|
| Age and gender characteristics | 6 months | |
| Age and gender distribution | 6 months | |
| Prescriber specialty distribution for patients |
Not provided
Inclusion Criteria:
Exclusion Criteria:
None
Not provided
Not provided
Not provided
This was a retrospective, noninterventional cohort study
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Novartis Pharmaceuticals | Novartis Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novartis | Basel | Switzerland |
Not provided
Not provided
Not provided
Not provided
| 6 months |